Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

HDV-Interferon in the Treatment of Chronic Hepatitis C Nonresponders and Naive Hepatitis C Patients

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified January 2009 by Hepasome Pharmaceuticals.
Recruitment status was:  Active, not recruiting
Sponsor:
Information provided by:
Hepasome Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00703872
First received: June 23, 2008
Last updated: January 8, 2009
Last verified: January 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2009
  Estimated Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)